In vivo assessment of pigmented skin lesions by Raman spectroscopy

In vivo assessment of pigmented skin lesions by Raman spectroscopy - RASKIN in vivo study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43252

Enrollment

100

Registered

2017-03-13

Start date

2017-01-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma mole. skin cancer of pigment-containing cells. Nevus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult, mentally competent persons with pigmented skin lesions

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - the lesion(s) are on body locations inaccessible to the Raman measurement - patient is physically capable of undergoing the Raman measurement (which requires the patient to not move during the measurement) - patient is mentally not capable of participation, e.g. because of anxiety

Design outcomes

Primary

Measure	Time frame
Clinical and when available the pathological diagnosis of the pigmented skin lesion (melanoma or benign skin lesion) will be correlated with the measured Raman spectra of the lesions.	—

Secondary

Measure	Time frame
Age of the patient, location and aspect of the lesion, clinical differential diagnosis.	—

Countries

Netherlands

Outcome results